Home
      Diagnosis
      Treatment
      Pathology
      Variants
      CIDP info
      GBS
        IVIG
        Diet
        About Us
         E-Book
       Email Web Weaver
       Autoimmune diseases
        News
        Links
 

 

 

 
 
      Skin repair Clinic
      Neck Pain
    Rabinder N Tagore
  Breast Lymph Drainage
      Osteoporosis
    Electronic Treatment
   Breast Size & Disease
      Female Sex Disease
    PARKINSON
    Memory problems
  Breast Lymph Drainage
 Kidney stone Buster
 Bras cause breast cancer
        Lahore Clinic
      Lahore skin Clinic
  Pandas

 

 

 
 

 

Home to autoimmune diseases,     Everything about IVIg,      Autoimmune diseases cure             Top clinic that cures cancer and autoimmune diseases,               Cure of Fibromyalgia,     Cure of Chronic Fatigue syndrome & Fibromyalgia,           Myofacial Pain the most common pain disorder in the world

Everything about IVIg, treatment, side effects

Fibromyalgia, diagnosis , symptoms , treatment

Kidney stone removal   without surgery

                           Treatment of inflammatory and paraproteinemic neuropathies
   Welcome to the CIDP  International organization

If the patient has a diagnosis of MUGAS or paraproteinemic polyneuropathy this is to be considered similar to CIDP or a autoimmune disorder. The treatment is similar.

  
   
  Please see our homepage for complete treatment guidelines                                           
 
 
Curr Drug Targets Immune Endocr Metabol Disord. 2004 Jun;4(2):141-8. Related Articles, Links

Treatment of inflammatory and paraproteinemic neuropathies.

Monaco S, Turri E, Zanusso G, Maistrello B.

Section of Clinical Neurology, Department of Neurological and Visual Sciences, University of Verona, Verona, Italy. salvatore.monaco@mail.univr.it

Acquired demyelinating and inflammatory neuropathies encompass a number of acute and chronic autoimmune conditions characterized by variable degrees of clinical involvement. These disorders, including Guillain-Barre syndrome (GBS), chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), multifocal motor neuropathy (MMN), and paraprotein-associated neuropathy, have an overall annual incidence of 2-4/100,000 worldwide and are potentially treatable. Over the last few years, several investigations have helped clarify the pathogenesis of immune neuropathies and the definition of molecular targets involved in these diseases, thus providing firmer grounds for treatment with classical immunosuppressive drugs and new biological agents. In GBS and related variants, which are characterized by cellular inflammation and alterations of the blood-nerve barrier, randomized clinical trials show that plasma exchange (PE) and intravenous immunoglobulin (IVIg) are equally effective as disease-modifying treatments, although IVIg has been adopted as the favourite treatment in most centres. In CIDP, controlled clinical trials have established the efficacy of oral prednisone, PE and IVIg, with intermittent IVIg treatment or corticosteroids being usually preferred. Adding azathioprine can help keep lower the required dose of prednisone, while other immunosuppressive agents, such as cyclophosphamide and cyclosporin A may have side effects, limiting their use to selected cases. Currently, the efficacy of interferon beta and alfa is under evaluation. Controlled trials support the view that IVIg is the treatment of choice in MMN. Patients resistant to IVIg administration may benefit of treatments which deplete B cells, such as cyclophosphamide and rituximab. Demyelinating neuropathies associated with circulating paraproteins are clinically heterogeneous, depending on the reactivity and type of the monoclonal (M) protein. In many cases, neuropathies associated with IgM M proteins are not treated because of their slow progression. In patients with a disabling or rapid progression, small trials have shown short-term benefits from IVIg or PE. Recently, fludarabine and rituximab have been reported as beneficial in selected cases.

Publication Types:
  • Review
  • Review, Tutorial

PMID: 15180454 [PubMed - indexed for MEDLINE]

 

Female sexual problems

Breast size and disease

Breast Lymph drainage

Bras causing breast cancer

Breast Size and disease

Eliminate risk of heart disease & stroke 

Memory clinic

Depression & anxiety

Private treatment of addiction  & Drug Rehab

Sexual  disorders Clinic

Parkinson Clinic

Epilepsy Clinic

Pain Clinic

Bone disorders clinic

Joint disorder clinic

Skin repair clinic

Gene Manipulation

Neurology Clinic

TMJ CLINIC

We offer a lecture on personality development and self improvement.

Is your teenage child out of your control we do behavior modification treatment with positive results and a 90% turnaround.

Our Nanoparticle treatment units are for sale. Get your treatment at home.

Sex in autoimmune disease

Reduce weight

Drug reaction prevention

Prevent Osteoporosis

Some rheumatic disorders

 

 
 

 

www.cidpusa.org  www.cidpusa.org/P/ivig.htm  http://www.cidpusa.org/disease.html http://www.cidpusa.org/Lahore.html